Recommended Pages at biomarkercommons.org
Videos: Recent Advances in Biomarkers of Parkinson's Disease | Biomarker Commons
biomarkercommons.org — “The Covance Symposium Recent Advances in Biomarkers of Parkinson’s Disease presented at the 2011 Society for Neuroscience Conference is now available to watch on the Covance website.” View full resource at biomarkercommons.org
Most Recently Shared on May 7, 2012 at 6:18 pm By:
Walter Jessen, PhD Pharma, Research, PhD, Active Health Library, and Doctor
Videos: Recent Advances in Biomarkers of Parkinson's Disease http://t.co/U4jD2q1b
New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer | Biomarker Commons
biomarkercommons.org — “Veridex, LLC announced today that it has joined with Novartis Pharmaceuticals Corporation in an educational alliance to encourage and facilitate research involving circulating tumor cells, or CTCs, as a potential biomarker in metastatic prostate cancer.” View full resource at biomarkercommons.org
Most Recently Shared on April 23, 2012 at 2:50 pm By:
Battelle Scientists Identify Potential Early Biomarker for Autism Spectrum Disorder | Biomarker Commons
biomarkercommons.org — “With recent research finding that autism spectrum disorder (ASD) affects one in 88 children in the U.S., Battelle scientists have identified a low-cost urine test that potentially predicts the presence of this complex developmental disorder at an early age.” View full resource at biomarkercommons.org
Most Recently Shared on April 23, 2012 at 2:47 pm By:
NextBio Announces NextBio Clinical, Integrates Patient Genomic Data | Biomarker Commons
biomarkercommons.org — “NextBio announced today NextBio Clinical, an extension of the company’s existing life sciences platform to translational medicine applications such as biomarker discovery and clinical trial optimization. NextBio Clinical enables the application of clinical information earlier in the discovery process to enhance research and development.” View full resource at biomarkercommons.org
Most Recently Shared on April 23, 2012 at 2:43 pm By:
Ezose Sciences and Hirosaki University to Collaborate in Glycomics Research to Find New Cancer Biomarkers | Biomarker Commons
biomarkercommons.org — “Ezose Sciences Inc. and Hirosaki University today announced that they have formed a collaboration in glycomics research to identify new biomarkers for use in predicting and monitoring the progression of prostate cancer and other urological cancers.” View full resource at biomarkercommons.org
Most Recently Shared on April 23, 2012 at 2:23 pm By:
Abcodia and BIOUNIVERSA Announce Collaboration on BAG3 Biomarker for the Early Detection of Pancreatic Cancer | Biomarker Commons
biomarkercommons.org — “Abcodia, a biomarker validation company, has today announced a collaboration with BIOUNIVERSA Srl, a spin off from the University of Salerno, which aims to advance the development of the BAG3 protein biomarker for use in the early detection of pancreatic cancer.” View full resource at biomarkercommons.org
Most Recently Shared on April 23, 2012 at 9:57 am By:
NextGen Files for Intellectual Property on Dementia Biomarkers | Biomarker Commons
biomarkercommons.org — “NextGen Group Plc (AIM: NGG), an AIM listed company providing biomarker discovery services and diagnostic assay development, announces that its subsidiary, NextGen Sciences Dx (NGSDx), has filed for intellectual property (IP) on a combination of protein biomarkers with the potential for diagnosing changes in cognition for patients with early-stage” View full resource at biomarkercommons.org
Most Recently Shared on March 20, 2012 at 4:26 pm By:
NephroCheck Test Aimed at Providing Risk Assessment Information for ICU Patients | Biomarker Commons
biomarkercommons.org — “Astute Medical, Inc., a developer of biomarker-based diagnostics intended to aid physicians in managing critically ill patients, today revealed its first product candidate, the NephroCheck Test, at the International Symposium on Intensive Care and Emergency Medicine (ISICEM) being held in Brussels, Belgium.” View full resource at biomarkercommons.org
Most Recently Shared on March 20, 2012 at 2:04 pm By:
Clinical Trial Examining Effects of Antioxidants for Alzheimer Disease on Cerebrospinal Fluid Biomarkers | Biomarker Commons
biomarkercommons.org — “An antioxidant combination of vitamin E, vitamin C and alpha-lipoic acid (E/C/ALA) was not associated with changes in some cerebrospinal fluid biomarkers related to Alzheimer disease in a randomized controlled trial, according to a study published Online First by Archives of Neurology, one of the JAMA/Archives journals.” View full resource at biomarkercommons.org
Most Recently Shared on March 20, 2012 at 1:59 pm By:
Biology Researcher on the Verge of a Technological Breakthrough in Drug Creation Process | Biomarker Commons
biomarkercommons.org — “New technology being developed at Florida State University could significantly decrease the cost of drug discovery, potentially leading to increased access to high-quality health care and cancer patients receiving personalized chemotherapy treatments.” View full resource at biomarkercommons.org
Most Recently Shared on March 16, 2012 at 11:16 am By:
Foundation of UMDNJ Receives Grand Challenges Tuberculosis Biomarkers Grant | Biomarker Commons
biomarkercommons.org — “The Foundation of UMDNJ, an affiliate of New Jersey Health Foundation, has received a tuberculosis (TB) biomarkers grant through the Bill & Melinda Gates Foundation's Grand Challenges in Global Health program, an initiative which seeks to overcome persistent bottlenecks in creating new tools that can radically improve health in the developing world” View full resource at biomarkercommons.org
Most Recently Shared on March 16, 2012 at 11:08 am By:
Biomarkers: New Tools of Modern Medicine | Biomarker Commons
biomarkercommons.org — “Over the last few decades there has been an explosion in the discovery of biomarkers for diagnosis, disease monitoring, and prognostic evaluation.” View full resource at biomarkercommons.org
Most Recently Shared on March 16, 2012 at 11:04 am By:
Quest Diagnostics Launches First Molecular Test for Kidney Organ Transplant Rejection | Biomarker Commons
biomarkercommons.org — “Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced the availability of the industry's first molecular blood test for identifying renal (kidney) organ-transplant rejection.” View full resource at biomarkercommons.org
Most Recently Shared on March 15, 2012 at 11:29 pm By:
AmberGen and Mass General License Two Novel Autoantigen Biomarkers for Autoimmune Liver Disease to INOVA Diagnostics | Biomarker Commons
biomarkercommons.org — “Two novel autoantigen biomarkers for the autoimmune liver disease Primary Biliary Cirrhosis (PBC), discovered by AmberGen, Inc., in collaboration with the Massachusetts General Hospital (MGH), were exclusively licensed to INOVA Diagnostics, Inc., part of the Werfen Group, and a world-leader in clinical assays for autoimmune disease.” View full resource at biomarkercommons.org
Most Recently Shared on March 15, 2012 at 12:00 pm By:
Selventa Receives Patent for Method to Identify Biomarker Profiles | Biomarker Commons
biomarkercommons.org — “Selventa, a biomarker discovery company that enables personalized healthcare through the stratification of patients based on disease-driving mechanisms, recently announced a US patent that relates methods and techniques that facilitate discovery of biomarkers, thus aiding in the development of predictive and prognostic diagnostic tests for therapeu” View full resource at biomarkercommons.org
